Scarica l'app Stockscreener
1.95
9.68%
-0.22
Dopo l'orario di chiusura:
1.94
-0.01
-0.51%
Precedente Chiudi:
$2.17
Aprire:
$2.12
Volume 24 ore:
108.09K
Relative Volume:
0.08
Capitalizzazione di mercato:
$1.11M
Reddito:
$4.60M
Utile/perdita netta:
$-6.25M
Rapporto P/E:
-0.0276
EPS:
-70.6412
Flusso di cassa netto:
$-15.38M
1 W Prestazione:
-21.60%
1M Prestazione:
+608.86%
6M Prestazione:
-40.24%
1 anno Prestazione:
-81.78%
Intervallo 1D:
$1.95
$2.13
Intervallo di 1 settimana:
$1.91
$2.69
Portata 52W:
$0.20
$26.16
Tc Biopharm Holdings Plc Adr Stock (TCBP) Company Profile
Nome
Tc Biopharm Holdings Plc Adr
Settore
Industria
Telefono
01414337557
Indirizzo
MAXIM 1, HOLYTOWN
Confronta TCBP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TCBP
Tc Biopharm Holdings Plc Adr
|
1.95 | 1.11M | 4.60M | -6.25M | -15.38M | -70.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
479.79 | 121.85B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
698.74 | 76.83B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
624.67 | 37.96B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
246.75 | 30.69B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beone Medicines Ltd Adr
|
271.80 | 29.71B | 3.32B | -860.46M | -1.04B | -8.32 |
Tc Biopharm Holdings Plc Adr Borsa (TCBP) Ultime notizie
What Lies Ahead For TC BioPharm (Holdings) plc ADR (NASDAQ: TCBP) In 2025? - Stocks Register
TC Biopharm completes initial Cohort B patient dosing in ACHIEVE trial - MSN
TC BioPharm Announces ADS Ratio Change - TipRanks
TC BioPharm (Holdings) plc ADR (TCBP) Stock: Uncovering 52-Week Market Trends - The InvestChronicle
TC BioPharm reports progress in AML treatment trial - Investing.com
TC BioPharm (Holdings) plc ADR (TCBP): A Technical Analysis - The News Heater
Ratios Reveal: Breaking Down TC BioPharm (Holdings) plc ADR (TCBP)’s Financial Health - The Dwinnex
Quarterly Snapshot: Quick and Current Ratios for ScanTech AI Systems Inc (STAI) - The Dwinnex
Upcoming Stock Splits This Week (February 10 to February 14) – Stay Invested - Markets Insider
Check Out TC BioPharm (Holdings) plc ADR (TCBP)’s Trade Data Rather Than the Analysts’ Views - SETE News
TC BioPharm's Major ADS Restructure: What This 1:20 Ratio Change Means For Your Holdings - StockTitan
TC BioPharm (Holdings) plc ADR (TCBP) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
TC Biopharm Faces Potential Nasdaq Delisting Due to Bid Price Non-Compliance - TipRanks
TC Biopharm Announces Special Stock Dividend and Temporary Trading Halt - TipRanks
TC BioPharm advances in acquisition strategy - Investing.com India
What Analysts Think About TC BioPharm (Holdings) plc ADR (NASDAQ: TCBP)’s Potential Raise - Stocks Register
TC BioPharm Approves Key Resolutions to Enhance Strategic Flexibility - TipRanks
No Stopping Argo Blockchain Plc ADR (NASDAQ: ARBK)’s Stock Plunged? - Stocks Register
NIO Inc ADR (NYSE: NIO) Stock Forecast: Could Pass $8 In A Year - Stocks Register
If You Don’t Buy Safe Pro Group Inc (NASDAQ: SPAI) Now, You’ll Regret It Later - Stocks Register
Would I Buy Opendoor Technologies Inc (NASDAQ: OPEN) Stock At Any Time In The Future? - Stocks Register
Tempest Therapeutics Inc (NASDAQ: TPST) Investors Should Be Worried About This. - Stocks Register
Where Do Analysts See Gamestop Corporation (NYSE: GME) Heading? - Stocks Register
TC BioPharm Advances Strategic Financial Initiative with New ADS Offering - TipRanks
TC BioPharm Announces Key Shareholder Meeting - TipRanks
TC Biopharm files $100M mixed securities shelf - TipRanks
TC Biopharm Faces Financial Strains Amid Rising Costs - TipRanks
TC Biopharm awarded funding of $250,000 from G-Rex Grant Program - TipRanks
TC BioPharm advances cancer therapy trials, raises $8M By Investing.com - Investing.com South Africa
TC BioPharm advances cancer therapy trials, raises $8M - Investing.com India
TC Biopharm refutes social media claim, remains compliant with Nasdaq rules - TipRanks
TC BioPharm denies Nasdaq delisting rumors - Investing.com
TC Biopharm enters research pact with Dr. Carlos Maluquer de Motes - TipRanks
United States shares mixed at close of trade; Dow Jones Industrial Average down 0.80% - Investing.com India
TC Biopharm (Holdings) PLC – ADR trading halted, volatility trading pause - TipRanks
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.80% - Investing.com
TCBP Stock Update: TC BioPharm (Holdings) plc ADR’s Banking’s Market Struggles and Potential Opportunities - The InvestChronicle
TC Biopharm announces artificial intelligene initiative with Carnegie Mellon - TipRanks
TCBP Announces Site Opening of Guys and St. Thomas Hospital - StockTitan
TC Biopharm announces first patient completes full dose regimen in ACHIEVE trial - TipRanks
TC BioPharm to start preclinical studies on monkeypox therapy - Investing.com India
TC Biopharm intends to launch preclinical study for treatment of Mpox - TipRanks
TC BioPharm to begin monkeypox treatment studies - Investing.com
TCBP’s Market Moves: -77.03% YTD Growth, -42.22% 6-Month loss, 68.52% in 30 Days - The InvestChronicle
TC BioPharm (Holdings) plc ADR (TCBP)’s stock rises to 7.28 per share - US Post News
TC Biopharm doses five new patients in the ACHIEVE Phase 2b trial in UK - TipRanks
TC Biopharm Unveils New Pre-Funded Warrant - TipRanks
Was there any good news for TC BioPharm (Holdings) plc ADR (TCBP) stock in the last session? - US Post News
Tc Biopharm Holdings Plc Adr Azioni (TCBP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.95%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):